Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-

Physiology and Behavior

Volumn 63, Issue 4, 1998, Pages 571-576

  Fiore, M ^a   Alleva, E ^b   Probert, L ^c   Kollias, G ^c   Angelucci, F ^a   Aloe, L ^a  

^a CNR   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Behavior; Cytokine; NGF; TNF (TNF ); Transgenic mice

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CYTOKINE RELEASE; DISPLACEMENT BEHAVIOR; EXPLORATORY BEHAVIOR; HUMAN; LOCOMOTION; MOUSE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOTYPY; TRANSGENIC MOUSE;

EID: 0032520162     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00514-3     Document Type: Article

References (60)

1. Akassoglou K., Probert L., Kontogeorgos G., Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:1997;438-445.
2. Alleva E., Aloe L., Bigi S. An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates. Rev. Neurosci. 4:1993;41-62.
3. Alleva E., Aloe L., Laviola G. Pretreatment of young mice with nerve growth factor enhances scopolamine-induced hyperactivity. Dev. Brain Res. 28:1986;278-281.
4. Aloe L., Probert L., Kollias G., Fiore M., Akassoglou K., Angelucci F. Nerve growth factor level in the brain of transgenic mice expressing TNF is differentially affected. Eur. Cytokine Netw. 7:1996;112.
5. Bernardini R., Kamilaris T. C., Calogero A. E., Johnson E. O., Gomez M. T., Gold P. W., Chrousos G. P. Interactions between TNF, hypothalamic corticotropin-releasing hormone and adrenocorticotropin secretion in the rat. Endocrinology. 126:1990;2871-2881.
6. Bernstein I. L., Taylor E. M., Bentson K. L. TNF-induced anorexia and learned food aversions are attenuated by area postrema lesions. Am. J. Physiol. 260:1991;R906-R910.
7. Bianchi M., Sacerdote P., Ricciardi-Castagnoli P., Mantegazza P., Panerai P. E. Central effects of TNF α and interleukin-1 (IL-1)a on nociceptive thresholds and spontaneous locomotor activity. Neurosci. Lett. 148:1992;76-80.
8. Bluthé R. M., Dantzer R., Kelley K. W. IL-1 mediates behavioural but not metabolic effects of TNF α in mice. Eur. J. Pharmacol. 209:1991;281-283.
9. Bluthé R. M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K. W., Dantzer R. Synergy between TNF α and IL-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology. 19:1994;197-207.
10. Bodnar R. J., Pasternak G. W., Mann P. E., Paul D., Warren R., Donner D. B. Mediation of anorexia by human recombinant TNF through a peripheral action in the rat. Cancer Res. 49:1989;6280-6284.
11. Boka G., Anglade P., Wallach D., Javoj-Agid G., Agid Y., Hirsch E. C. Immunocytochemical analysis of TNF and its receptors in Parkinson's disease. Neurosci. Lett. 172:1994;151-154.
12. Breder C. D., Tsujimoto M., Terano Y., Scott D. W., Saper C. B. Distribution and characterization of TNF-α-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 337:1993;543-567.
13. Bruce A. J., Boling W., Kindy M. S., Peschon J., Kraemer P. J., Carpenter M. K., Holtsberg F. W., Mattson M. P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2:1996;788-794.
14. Buhot M. C., Naili S. Changes in exploratory activity following stimulation of hippocampal 5-HT1A and 5-HT1B receptors in the rat. Hippocampus. 5:1995;198-203.
15. Calamandrei G., Valanzano A. Age-dependent effects of NGF and scopolamine on suckling behavior of neonatal mice. Pharmacol. Biochem. Behav. 49:1994;1043-1048.
16. Calamandrei G., Valanzano A., Alleva E. NGF and cholinergic control of behavior anticipation and enhancement of scopolamine effects in neonatal mice . Dev. Brain Res. 61:1991;237-241.
17. Cheng B., Christakos S., Mattson M. P. TNFs protect neurons against metabolic-exitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
18. Cools A. R., Wiegant V. M., Gispen W. H. Distinct dopaminergic system in ACTH-induced grooming. Eur. J. Pharmacol. 50:1978;265-278.
19. Costall B., Jones B. J., Kelly M. E., Naylor R. J., Tomkins D. M. Exploration of mice in a black and white test box Validation as a model of anxiety . Pharmacol. Biochem. Behav. 32:1989;777-785.
20. de Bock F., Dornand J., Rondouin G. Release of TNF-α in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. NeuroReport. 7:1996;1125-1129.
21. Dinarello C. A. The proinflammatory cytokines IL-1 and TNF and treatment of the septic shock syndrome. J. Inf. Dis. 163:1991;1177-1184.
22. Dunn A. J., Vigle G. Grooming behavior induced by ACTH involves cerebral cholinergic neurons and muscarinic receptors. Neuropharmacolology. 24:1985;329-331.
23. Durig J., Fiedler W., de Wit M., Steffen M., Hossfeld D. K. Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated TNF-α Ann. Hematol. 72:1996;97-99.
24. Fantino M., Wieteska L. Evidence for a direct central anorectic effect of tumor-necrosis-factor-α in the rat. Physiol. Behav. 53:1993;477-483.
25. Fiore M., Dell'Omo G., Alleva E., Lipp H-P. A comparison of behavioural effects of prenatally administered oxazepam in mice exposed to open-fields in the laboratory and the real world. Psychopharmacology. 122:1995;72-77.
26. Fiore M., Probert L., Kollias G., Akassoglou K., Alleva E., Aloe E. Neuro-behavioural alterations on developing tg-m mice expressing TNF-α in the brain. Brain Behav. Immun. 10:1996;126-138.
27. Harthgraves S. L., Randall P. K. Dopamine agonist-induced stereotypic depletion. Psychopharmacology. 90:1986;358-363.
28. Hattori A., Hayashi K., Kohno M. TNF stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor. FEBS Lett. 379:1996;157-160.
29. Hattori A., Tanaka E., Murase B. K., Ishida N., Chatani Y., Tsujimoto M., Hayashi K., Kohno M. TNF stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J. Biol. Chem. 268:1993;2577-2582.
30. Hermann G., Rogers R. C. TNF-α in the dorsal vagal complex suppresses gastric motility. Neuroimmunomodulation. 2:1995;74-81.
31. Kapas L., Hong L., Cady A. B., Opp M. R., Postlethwaite A. E., Seyer J. M., Krueger J. M. Somnogenic, pyrogenic, and anorectic activities of TNF-α and TNF-α fragments. Am. J. Physiol. 263:1992;R708-R715.
32. Kawasaki H., Moriyama M., Ohtani Y., Naitoh M., Tanaka A., Nariuchi H. Analysis of endotoxin fever in rabbits by using a monoclonal antibody to TNF (cachectin). Infect. Immun. 57:1989;3131-3135.
33. Kluger M. J. Fever Role of pyrogens and cryogens . Physiol. Rev. 71:1991;93-127.
34. Leanza G., Nilsson O. G., Wiley R. G., Bjorklund A. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin Behavioural, biochemical and stereological studies in the rat . Eur. J. Neurosci. 7:1995;329-343.
35. Leist T. P., Frei K., Kam-Hansen S., Zinkernagel R. M., Fontana A. TNF α in cerebrospinal fluid during bacterial, but not viral, meningitis Evaluation in murine model of infections and in patients . J. Exp. Med. 167:1988;1743-1748.
36. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
37. Levi-Montalcini R., Skaper. S. D.; Dal Toso R., Petrelli L., Leon A. Nerve growth factor From neurotrophin to neurokine . Trends Neurosci. 19:1996;514-520.
38. Mackintosh J. H. Behaviour of the house mouse. Symp. Zool. Soc. Lond. 47:1981;337-365.
39. Makanjuola R. O. A., Hill G., Maben I., Cow R. C., Ashcroft G. W. An automated method for studying exploratory and stereotyped behaviour in rats. Psychopharmacology. 52:1977;271-277.
40. Merrill J. E. TNF α, interleukin 1 a, interleukin 1 and related cytokines in brain development Normal and pathological . Dev. Neurosci. 14:1992;1-10.
41. Minami M., Kuraishi Y., Satho M. Effects of kainic acid on messenger RNA levels of IL-1 β, IL-6, TNF α and LIF in the rat brain. Biochem. Biophys. Res. Comm. 176:1991;593-598.
42. Mogi M., Harada M., Riederer P., Narabayashi H., Fuyita K., Nagatsu T. TNF-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165:1994;208-210.
43. Morris R. G. M. Neural subsystems of exploration in rats. Archer J., Birke L.I.A. Exploration in animals and humans. 1983;117-145 Van Nostrand Reinhold, Wokingham.
44. Netto S. M., Guimaraes F. S. Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience. Behav. Brain Res. 77:1996;215-218.
45. Olton D. S., Markowska A. L. Memory and hippocampal function as targets for neurotoxic substances. Neurotoxicology. 15:1994;439-444.
46. Plata-Salaman C. R., Oomura Y., Kay J. TNF and IL-1β suppression of food intake by direct action in the central nervous system . Brain Res. 448:1988;106-114.
47. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing CNS-specific TNF-α expression. Proc. Natl. Acad. Sci. USA. 92:1995;11294-11298.
48. Selmaj K., Raine C. S., Cannella B., Brosnan C. S. Identification of lymphotoxin and TNF in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
49. Spruijt B. M., Van Hoof J. A. R. A. M., Gispen W. H. Ethology and neurobiology of grooming behavior. Physiol. Rev. 72:1992;825-852.
50. Strieter R. M., Kunkel S. L. Acute lung injury The role of cytokines in the elicitation of neurotrophils . J. Invest. Med. 42:1994;640-651.
51. Tchelingerian J. L., Vignais L., Jacque C. TNF-α gene expression is induced in neurones after a hippocampal lesion. NeuroReport. 5:1994;585-588.
52. Thoenen H., Bandtlow C., Heumann R. The physiological function of nerve growth factor in the central nervous system Comparison with the periphery . Rev. Physiol. Biochem. Pharmacol. 109:1987;146-171.
53. Torre E., Celis M. E. α-MSH injected into the substantia nigra or intraventricularly Behaviour and the striatal dopaminergic activity . Neurochem. Int. 9:1986;85-89.
54. Tracey K. J., Cerami A. TNF A pleiotropic cytokine and therapeutic target . Ann. Rev. Med. 45:1994;491-503.
55. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L., Griffin D. E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
56. Ungersted U., Arbuthnott G. Quantitative recording of rotational behaviour in rats after 6-hydroxidopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
57. Vassalli P. The pathophysiology of TNFs. Ann. Rev. Immunol. 10:1992;411-452.
58. Vilcek J., Lee T. H. TNF. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:1991;7313-7316.
59. Watkins L. R., Goehler L. E., Relton J., Brewer M. T., Maier S. F. Mechanisms of TNF-α (TNF-α) hyperalgesia. Brain Res. 692:1995;244-250.
60. Winter B. K., Fiskum G., Gallo L. L. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br. J. Cancer. 72:1995;1173-1179.